Booster vaccines for COVID-19 vaccine breakthrough cases? – Authors' reply

por Krause, Philip R, Rees, Helen, Figueroa, J Peter, Swaminathan, Soumya, Restrepo, Ana Maria Henao
Publicado 2022

Electronic Data Management for Vaccine Trials in Low Resource Settings: Upgrades, Scalability, and Impact of ODK

por Marks, Michael, Lal, Sham, Brindle, Hannah, Gsell, Pierre-Stéphane, MacGregor, Matthew, Stott, Callum, van de Rijdt, Martijn, Almazor, Guillermo Gutiérrez, Golia, Suman, Watson, Conall, Diallo, Abdourahamane, Toure, Alhassane, Houlihan, Catherine, Keating, Patrick, Martin, Hélène, Restrepo, Ana-Maria Henao, Anokwa, Yaw, Roberts, Chrissy H.
Publicado 2021

Viewpoint of a WHO Advisory Group Tasked to Consider Establishing a Closely-Monitored Challenge Model of COVID-19 in Healthy Volunteers

por Levine, Myron M, Abdullah, Salim, Arabi, Yaseen M, Darko, Delese Mimi, Durbin, Anna P, Estrada, Vicente, Jamrozik, Euzebiusz, Kremsner, Peter G, Lagos, Rosanna, Pitisuttithum, Punnee, Plotkin, Stanley A, Sauerwein, Robert, Shi, Sheng-Li, Sommerfelt, Halvor, Subbarao, Kanta, Treanor, John J, Vrati, Sudhanshu, King, Deborah, Balasingam, Shobana, Weller, Charlie, Aguilar, Anastazia Older, Cassetti, M Cristina, Krause, Philip R, Restrepo, Ana Maria Henao
Publicado 2020